y 27632 has been researched along with Experimental Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, DJ; Cho, Y; Choi, Y; Hong, Y; Kim, IS; Kim, YK; Kwon, IC; Lee, EJ; Nam, GH; Park, SY; Ryu, MJ; Woo, J; Yang, Y | 1 |
| Aihara, Y; Akasu, T; Fujita, S; Ishiguro, T; Nakagama, H; Ohata, H; Okamoto, K; Sakai, H; Sato, A; Sekine, S; Taniguchi, H | 1 |
| Giri, S; Rattan, R; Singh, AK; Singh, I | 1 |
3 other study(ies) available for y 27632 and Experimental Neoplasms
| Article | Year |
|---|---|
Combined Rho-kinase inhibition and immunogenic cell death triggers and propagates immunity against cancer.
Topics: Amides; Animals; Antineoplastic Combined Chemotherapy Protocols; CD8-Positive T-Lymphocytes; Cell Death; Cell Line, Tumor; Cells, Cultured; Cisplatin; Dendritic Cells; Doxorubicin; Humans; Immunity; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Neoplasms, Experimental; Protein Kinase Inhibitors; Pyridines; rho-Associated Kinases; T-Lymphocytes, Cytotoxic | 2018 |
Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells.
Topics: Amides; Animals; Apoptosis; Blotting, Western; Cell Proliferation; Colonic Neoplasms; Enzyme Inhibitors; Gene Expression Profiling; Hep G2 Cells; Heterocyclic Compounds, 4 or More Rings; HT29 Cells; Humans; Hyaluronan Receptors; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasms, Experimental; Neoplastic Stem Cells; Oligonucleotide Array Sequence Analysis; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; rho-Associated Kinases; RNA Interference; Spheroids, Cellular; Transplantation, Heterologous; Tumor Cells, Cultured | 2012 |
Rho/ROCK pathway as a target of tumor therapy.
Topics: Amides; Animals; Antineoplastic Agents; Apoptosis; Blotting, Southern; Blotting, Western; Caspases; Cell Survival; Disease Models, Animal; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Inhibitors; Flow Cytometry; Humans; Immunohistochemistry; In Situ Nick-End Labeling; Intracellular Signaling Peptides and Proteins; Lovastatin; Male; Mevalonic Acid; Mice; Neoplasms; Neoplasms, Experimental; Polyisoprenyl Phosphates; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Wistar; rho-Associated Kinases; rhoA GTP-Binding Protein; Signal Transduction; Tetrazolium Salts; Thiazoles; Time Factors; Tumor Cells, Cultured | 2006 |